MedPath

Endothelial Function Study Before Cardiovascular Surgery

Terminated
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Obstructive Sleep Apnea Syndrome (OSAS)
Registration Number
NCT01195064
Lead Sponsor
University Hospital, Grenoble
Brief Summary

The aim of this clinical trial is to evaluate the effect of chronic obstructive pulmonary disease (COPD) and/or obstructive sleep apnea syndrome (OSAS) on the endothelial function, before cardiovascular surgery, compared to non COPD non OSAS patients undergoing also a cardiovascular surgery, by an observational physiological study.

An interim analysis will be performed when 100 patients will be included.

Detailed Description

Secondary objectives of this clinical trial :

* To evaluate the effect of COPD and/or OSAS on the systemic inflammation, insulin-resistance and oxydative stress, in comparison with non COPD non OSAS patients.

* To evaluate the effect of COPD and/or OSAS on the inflammation and oxydative stress of the adipose tissue, in comparison with non COPD non OSAS patients.

* To validate the STOP-BANG questionnaire in patients undergoing a cardiovascular surgery

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Men or women between 18 and 80 years old
  • Patient with planned coronary artery bypass graft surgery
  • Patient with planned peripheral vascular surgery
  • Patient with aortic surgery
Exclusion Criteria
  • Patient with aortic or mitral valvular replacement
  • Patient with emergency peripheral valvular surgery
  • Patient with emergency coronary artery bypass graft surgery
  • Patient with evolutive malignancy disease
  • Pregnant or lactating women
  • Patient with inadvisable bronchodilator (used for functional respiratory) exploration

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the percent of peripheral arterial tone (PAT) in COPD and/or OSAS patients compared to non COPD non OSAS patients.one week before their cardiovascular surgery
Secondary Outcome Measures
NameTimeMethod
Polysomnographyone week before their cardiovascular surgery
Evaluation of the systemic inflammation, insulin-resistance and oxidative stress occurring during COPD and/or OSAS patients compared to non COPD non OSAS patients.one week before their cardiovascular surgery
Evaluation of adipose tissue inflammation and oxidative stress occurring during COPD and/or OSAS patients compared to non COPD non OSAS patients.one week before their cardiovascular surgery
Functional respiratory explorationone week before their cardiovascular surgery

Trial Locations

Locations (3)

University Hospital of Angers

🇫🇷

Angers, France

Mutualist Hospital group

🇫🇷

Grenoble, France

University Hospital of Grenoble

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath